BeiGene Ltd (BGNE)
148.56
-5.70
(-3.69%)
USD |
NASDAQ |
May 31, 16:00
148.78
+0.22
(+0.15%)
After-Hours: 20:00
BeiGene Gross Profit Margin (Quarterly): 83.38% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 83.38% |
December 31, 2023 | 83.32% |
September 30, 2023 | 87.67% |
June 30, 2023 | 83.87% |
March 31, 2023 | 81.74% |
December 31, 2022 | 80.66% |
September 30, 2022 | 80.25% |
June 30, 2022 | 79.16% |
March 31, 2022 | 78.72% |
December 31, 2021 | 77.31% |
September 30, 2021 | 77.03% |
June 30, 2021 | 75.82% |
March 31, 2021 | 94.61% |
December 31, 2020 | 78.94% |
Date | Value |
---|---|
September 30, 2020 | 76.81% |
June 30, 2020 | 78.20% |
March 31, 2020 | 72.82% |
December 31, 2019 | 68.39% |
September 30, 2019 | 59.90% |
June 30, 2019 | 92.67% |
March 31, 2019 | 80.39% |
December 31, 2018 | 84.33% |
September 30, 2018 | 83.94% |
June 30, 2018 | 88.15% |
March 31, 2018 | 86.02% |
December 31, 2017 | 83.33% |
September 30, 2017 | 99.12% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
59.90%
Minimum
Sep 2019
94.61%
Maximum
Mar 2021
79.56%
Average
79.05%
Median
Gross Profit Margin (Quarterly) Benchmarks
Theravance Biopharma Inc | -- |
LumiraDx Ltd | -47.14% |
Dr Reddy's Laboratories Ltd | 70.46% |
Jazz Pharmaceuticals PLC | 89.41% |
Zai Lab Ltd | 61.42% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -21.07% |
Return on Assets | -13.67% |
Return on Invested Capital | -17.69% |
Profit Margin (Quarterly) | -33.41% |
Operating Margin (Quarterly) | -34.77% |
Return on Net Operating Assets | -34.65% |